11.01.03
Enzymotec, Migdal HaEmeq, Israel, has signed an exclusive agreement with Korea-based Nics Corporation Ltd. According to the agreement, Nics will exclusively market Enzymotec’s InFat product to the dairy and infant formula markets in Korea. InFat is designed to imitate mother’s milk in infant formulas.